Stora Enso Oyj ser. R (STE-R)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 110.10 |
|---|---|
| 52-week range | 96.85 – 129.40 |
| Return, 1 month / 3 months | −6.9% / +3.7% |
| Return, 1 year / 3 years | +3.8% / −15.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 24.93M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stora Enso is a forest products company based in Finland that makes renewable materials from wood. It produces packaging materials such as containerboard and cartons, paper grades, and wood products including timber and building components, and it also supplies pulp and biomaterials. Its customers are packaging converters, publishers, printers, construction firms and other industrial users, and it manages forests and mills across the Nordic countries and beyond.
Stora Enso Oyj ser. R trades under the code STE-R on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stora Enso Oyj ser. R (STE-R) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 110.10 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 107 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.8% and over the last three months it rose 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -13.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.7% | ||
| 6-month return | 5.8% | ||
| 12-month return, skipping the last month | 11.4% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 24.93M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −6.9% |
| 3 months | +3.7% |
| 6 months | +5.8% |
| 1 year | +3.8% |
| 3 years | −15.6% |
| 5 years | −23.6% |
Signals
| 50-day / 200-day average | 112.96 / 110.02 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Mar 2021 | EUR 3.0425 |
| 9 Dec 2020 | EUR 0.1500 |
| 5 Jun 2020 | EUR 1.5661 |
| 20 Mar 2020 | EUR 0.5000 |
| 15 Mar 2019 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.